Pheromone Signaling in Pneumocystis Carinii
卡氏肺孢子虫中的信息素信号转导
基本信息
- 批准号:6450166
- 负责人:
- 金额:$ 32.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-03-01 至 2005-02-28
- 项目状态:已结题
- 来源:
- 关键词:Pneumocystis carinii antibody biological signal transduction cell cycle cell cycle proteins cell growth regulation cell proliferation complementary DNA enzyme activity enzyme inhibitors flow cytometry fungal genetics gene expression immunoelectron microscopy immunoprecipitation light microscopy meiosis messenger RNA mitogen activated protein kinase pheromone polymerase chain reaction pulsed field gel electrophoresis tissue /cell culture western blottings
项目摘要
DESCRIPTION (provided by applicant): Pneumocystis carinii is an opportunistic
fungal pathogen which causes severe pneumonia in patients with impaired
immunity such as patients with AIDS. The life cycle of P. carinii is poorly
understood. In fungi related to P. carinii, nutrient deprivation and
dessication are the major stimuli for the release of pheromone mating factors
which activate a mitogen-activated protein kinase (MAPK), resulting in mitotic
cell cycle arrest, conjugation and meiosis, and increased pathogenicity. MAPK
is the essential molecule in the pheromone-induced signal transduction cascade
which controls these events. As an essential molecule regulating an organism's
life cycle, MAPK activity is highly regulated. Dual phosphorylations are
requiring for activation, and variable MAPK activity and expression are
restricted to certain life cycle forms. Our initial studies indicate that P.
carinii possesses a MAPK which is closely related to fungal pheromone-induced
MAPKs. We hypothesize that the pheromone-induced mitogen-activated protein
kinase (MAPK) signal transduction cascade regulates cellular differentiation
and proliferation of P. carinii organisms. As an essential component in the
life cycle of fungi, investigation of the P. carinii MAPK will result in an
enhanced understanding of the P. carinii life cycle, pathogenicity, and lead to
development of novel therapeutic agents to treat P. carinii pneumonia. To
evaluate these hypotheses, we will undertake several parallel investigations.
MAPK activity and expression in separated life cycle forms will be accessed to
determine whether P. carinii MAPK is differentially regulated over the P.
carinii life cycle. We will identify and characterize the P. carinii pheromone
receptors and separate P. carinii mating types by FACS. We will access whether
nutrient deprivation, hypoxia, or temperature changes results in mitotic cell
cycle arrest leading to meiosis and formation of the cyst, and whether
inhibitors of the MAPK cascade block these effects. We will also investigate if
isolated mating types undergo haploid mitosis or if mixing of mating types is
essential for meiosis and formation of the cyst. Through these investigations,
we hope to gain important insights into the life cycle regulation and
pathogenicity ofP. carinii.
描述(由申请人提供):卡氏肺孢子虫是一种机会性
真菌病原体导致严重肺炎的患者受损
免疫力低下,如艾滋病患者。卡氏肺孢子虫的生活史
明白在与卡氏肺孢子虫相关的真菌中,营养缺乏和
干燥是交配因子释放的主要刺激
其激活促分裂原活化蛋白激酶(MAPK),导致有丝分裂。
细胞周期阻滞、接合和减数分裂,以及致病性增加。MAPK
是信息素诱导的信号转导级联反应中的重要分子
控制着这些事件作为一种重要的分子,
在生命周期中,MAPK活性受到高度调节。双磷酸化是
需要激活,可变的MAPK活性和表达是
仅限于某些生命周期形式。我们的初步研究表明,P。
carinii具有与真菌信息素诱导的
MAPKs我们假设信息素诱导的丝裂原活化蛋白
MAPK信号转导级联调控细胞分化
以及卡氏肺孢子虫生物体的增殖。作为一个重要组成部分,
真菌的生命周期,卡氏疟原虫MAPK的研究将导致
加强对卡氏肺孢子虫生命周期、致病性和导致
开发治疗卡氏肺孢子虫肺炎的新型治疗剂。到
评估这些假设,我们将进行几个平行的调查。
分离的生命周期形式中的MAPK活性和表达将被访问,
确定卡氏肺孢子虫MAPK是否相对于卡氏肺孢子虫受到差异调节。
卡氏虫生活史我们将鉴定并描述卡氏疟原虫信息素
受体和单独的卡氏肺孢子虫交配型。我们将访问是否
营养缺乏、缺氧或温度变化导致有丝分裂细胞
周期停滞导致减数分裂和囊肿的形成,以及是否
MAPK级联的抑制剂阻断这些作用。我们还将调查,
分离的交配型进行单倍体有丝分裂,或者如果交配型的混合,
对于减数分裂和包囊的形成至关重要。通过这些调查,
我们希望获得对生命周期监管的重要见解,
致病性P. carinii。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHARLES FRANCIS THOMAS其他文献
CHARLES FRANCIS THOMAS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHARLES FRANCIS THOMAS', 18)}}的其他基金
LIFE CYCLE REGULATION OF PNEUMOCYSTIS CARINII BY MAPK
MAPK 对卡氏肺囊虫生命周期的调控
- 批准号:
6168734 - 财政年份:1998
- 资助金额:
$ 32.51万 - 项目类别:
LIFE CYCLE REGULATION OF PNEUMOCYSTIS CARINII BY MAPK
MAPK 对卡氏肺囊虫生命周期的调控
- 批准号:
2886123 - 财政年份:1998
- 资助金额:
$ 32.51万 - 项目类别:
LIFE CYCLE REGULATION OF PNEUMOCYSTIS CARINII BY MAPK
MAPK 对卡氏肺囊虫生命周期的调控
- 批准号:
2708830 - 财政年份:1998
- 资助金额:
$ 32.51万 - 项目类别:
相似海外基金
Development of B cell functional studies on primary antibody deficiencies
一抗缺陷 B 细胞功能研究的进展
- 批准号:
502607 - 财政年份:2024
- 资助金额:
$ 32.51万 - 项目类别:
Thymus antibody-secreting cells: major players in autoimmunity.
胸腺抗体分泌细胞:自身免疫的主要参与者。
- 批准号:
502578 - 财政年份:2024
- 资助金额:
$ 32.51万 - 项目类别:
ICF: AbVax Combination vaccination and broadly neutralising antibody therapy in HIV to induce a protective Tcell vaccinal effect, a mechanistic study
ICF:AbVax 联合疫苗接种和广泛中和 HIV 抗体疗法诱导保护性 T 细胞疫苗效应,一项机制研究
- 批准号:
MR/Y008847/1 - 财政年份:2024
- 资助金额:
$ 32.51万 - 项目类别:
Research Grant
Enabling The Targeted Delivery Of DNA G-quadruplex Ligands using a Novel Antibody DAR-1 Platform
使用新型抗体 DAR-1 平台实现 DNA G 四链体配体的靶向递送
- 批准号:
BB/Y002180/1 - 财政年份:2024
- 资助金额:
$ 32.51万 - 项目类别:
Research Grant
Antibody-Palladium Conjugates for Bioorthogonal Anti-Cancer Prodrug Activation
用于生物正交抗癌前药激活的抗体-钯缀合物
- 批准号:
EP/Y024540/1 - 财政年份:2024
- 资助金额:
$ 32.51万 - 项目类别:
Fellowship
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
- 批准号:
24K19237 - 财政年份:2024
- 资助金额:
$ 32.51万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
A Semi-Automated Antibody-Discovery Platform to Target Challenging Biomolecules
针对具有挑战性的生物分子的半自动化抗体发现平台
- 批准号:
MR/Y003616/1 - 财政年份:2024
- 资助金额:
$ 32.51万 - 项目类别:
Fellowship
Monitoring antibody protection against SARS-CoV-2 variants
监测抗体对 SARS-CoV-2 变体的保护作用
- 批准号:
MR/Y033698/1 - 财政年份:2024
- 资助金额:
$ 32.51万 - 项目类别:
Research Grant
Autoantibodies and antibody-secreting cells in neurological autoimmune diseases: from biology to therapy
神经性自身免疫性疾病中的自身抗体和抗体分泌细胞:从生物学到治疗
- 批准号:
479128 - 财政年份:2023
- 资助金额:
$ 32.51万 - 项目类别:
Operating Grants
Pharmacokinetic analysis of antibody drug conjugate in tumor cells utilizing synchrotron soft X-ray imaging
利用同步加速器软 X 射线成像对肿瘤细胞中抗体药物偶联物进行药代动力学分析
- 批准号:
23H03716 - 财政年份:2023
- 资助金额:
$ 32.51万 - 项目类别:
Grant-in-Aid for Scientific Research (B)